We are live on ! Find out more
NKGNW

NKGen Biotech, Inc. Warrants
NKGNW

Delisted

NKGNW was delisted on the 4th of March, 2025.

Back to rankings

26 hedge funds and large institutions have $268K invested in NKGen Biotech, Inc. Warrants in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

68% more capital invested

Capital invested by funds: $159K → $268K (+$108K)

10% less funds holding

Funds holding: 29 → 26 (-3)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

Holders
26
Holders Change
-3
Holders Change %
-10.34%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
3
Closed
5
Calls
$3K
Puts
–
Net Calls
+$3K
Net Calls Change
+$1K

Top Buyers

Rank Fund Capital Flow
1
MF
Magnetar Financial
Illinois
+$36.4K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.08K
3
FTUS
Flow Traders U.S.
New York
+$666
4
SFA
Sequoia Financial Advisors
Ohio
+$589

Top Sellers

Rank Fund Capital Flow
1
SCM
Shaolin Capital Management
Florida
-$9.07K
2
Walleye Capital
Walleye Capital
New York
-$3.25K
3
FBCM
Fort Baker Capital Management
California
-$2.61K
4
Walleye Trading
Walleye Trading
New York
-$1.83K
5
WAM
Wolverine Asset Management
Illinois
-$681
Name Holding Trade Value Shares
Change 		Change in
Stake
MF
1
Magnetar Financial
Illinois
$71.3K +$36.4K +713,357 New
RCM
2
Rivernorth Capital Management
Florida
$65.2K – – –
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$15.9K – – –
BNP Paribas Financial Markets
4
BNP Paribas Financial Markets
France
$15K – – –
Balyasny Asset Management
5
Balyasny Asset Management
Illinois
$14K – – –
Jane Street
6
Jane Street
New York
$10K – – –
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
7
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$10K – – –
EAM
8
Exos Asset Management
New York
$8.84K – – –
TCA
9
Taconic Capital Advisors
New York
$6.99K – – –
PAMP
10
Polar Asset Management Partners
Ontario, Canada
$6K – – –
SFA
11
Sequoia Financial Advisors
Ohio
$5.67K +$589 +11,550 +26%
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$5K – – –
AIMCA
13
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$4K – – –
MTCM
14
Mint Tower Capital Management
Netherlands
$4K – – –
SCM
15
Saba Capital Management
New York
$3.5K – – –
BOCH
16
Blue Owl Capital Holdings
New York
$3K – – –
SSA
17
Schonfeld Strategic Advisors
New York
$3K – – –
FTUS
18
Flow Traders U.S.
New York
$3K +$666 +13,051 +106%
Citadel Advisors
19
Citadel Advisors
Florida
$2.58K -$95 -1,864 -7%
Susquehanna International Group
20
Susquehanna International Group
Pennsylvania
$2.13K +$1.08K +21,249 New
GCIA
21
Gabelli & Co Investment Advisers
New York
$1.72K – – –
GF
22
Gabelli Funds
New York
$1.72K – – –
WAM
23
Wolverine Asset Management
Illinois
$1.45K -$681 -13,345 -48%
UBS Group
24
UBS Group
Switzerland
$1.36K -$49 -963 -7%
CL
25
CSS LLC
Illinois
$1.28K – – –
1
2

NKGNW Hedge Fund Activity: Q4 2024 in Review

26 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in NKGen Biotech, Inc. Warrants (NKGNW) for Q4 2024, worth a combined $268K — up 68% from $159K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of NKGNW and 2 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was Magnetar Financial, opening a new position worth an estimated $36.4K. The largest seller was Shaolin Capital Management, exiting entirely with an estimated $9.07K sold.

  • 26 institutional investors held NKGen Biotech, Inc. Warrants (NKGNW) as of Q4 2024, down from 29 in Q3 2024.
  • Funds reported $268K of NKGen Biotech, Inc. Warrants stock for Q4 2024, up 68% quarter-over-quarter.
  • 2 funds opened new NKGen Biotech, Inc. Warrants positions in Q4 2024 and 5 closed out, a net change of -3 holders.
  • The largest NKGen Biotech, Inc. Warrants buyer in Q4 2024 was Magnetar Financial, an estimated $36.4K added.
  • The largest NKGen Biotech, Inc. Warrants seller in Q4 2024 was Shaolin Capital Management, an estimated $9.07K sold.

Based on aggregated 13F filings for Q4 2024.